Axial Biotherapeutics
Founded 2016 · $62.3M raised
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- axialbiotherapeutics.com
- Total Funding
- $62.3M
- Last Round
- $37.3M Series COct 2021
- Rounds
- 2
About
Axial Biotherapeutics is a clinical-stage biopharmaceutical company developing therapies for central nervous system diseases and disorders. Its research uses the gut-brain axis to identify and develop novel treatments intended to improve patients' quality of life. The company advances therapeutic programs that translate microbiome and neurological science into potential medicines for CNS conditions.
Summary
Axial Biotherapeutics is a Biotech company, founded in 2016. It has raised $62.3M in total across 2 rounds, most recently a $37.3M Series C round in Oct 2021.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Oct 2021
Sign up to see all 2 rounds
Series B through Series C — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/axial-biotherapeutics"><img src="https://indexed.vc/api/badge/company/axial-biotherapeutics" alt="Axial Biotherapeutics on Indexed.vc" width="260" height="76" /></a>